BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15700013)

  • 1. [Epidemiological features of recurrent ENT mycoses and experience in their treatment with systemic antifungal drug intraconazole (orungamin)].
    Eremina NV; Vladimirova TIu; Denisov MV; Egortseva ON
    Vestn Otorinolaringol; 2005; (1):52-3. PubMed ID: 15700013
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
    Agarwal PK; Roy P; Das A; Banerjee A; Maity PK; Banerjee AR
    Indian J Ophthalmol; 2001 Sep; 49(3):173-6. PubMed ID: 15887725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable antifungal approved.
    AIDS Patient Care STDS; 1999 Jul; 13(7):442. PubMed ID: 10870607
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC).
    Ogawa H; Fujimura M; Takeuchi Y; Makimura K
    J Asthma; 2009 May; 46(4):407-12. PubMed ID: 19484679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
    Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term administration of itraconazole with surgical treatment in fungal and bacterial infections of the paranasal sinuses].
    Jordan J; Sova J
    Otolaryngol Pol; 2003; 57(6):813-7. PubMed ID: 15049180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal agents and the treatment of fungal infections of the head and neck.
    Neibart E; Gumprecht J
    Otolaryngol Clin North Am; 1993 Dec; 26(6):1123-31. PubMed ID: 8290285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fungus diseases in the ENT area and their treatment].
    Stüttgen G
    Z Laryngol Rhinol Otol; 1969 Feb; 48(2):114-8. PubMed ID: 5780952
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otomycosis: clinical features and treatment implications.
    Ho T; Vrabec JT; Yoo D; Coker NJ
    Otolaryngol Head Neck Surg; 2006 Nov; 135(5):787-91. PubMed ID: 17071313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual case of lung abscess caused by Acremonium species treated with itraconazole.
    Qazi MS; Bowalekar SS; Wanjare VS; Shankar A
    Indian J Med Microbiol; 2015; 33(2):307-10. PubMed ID: 25865993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.
    Chaiwarith R; Charoenyos N; Sirisanthana T; Supparatpinyo K
    AIDS; 2007 Jan; 21(3):365-7. PubMed ID: 17255744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1-day and a 3-day regimen.
    Spacek J; Buchta V
    Mycoses; 2005 May; 48(3):165-71. PubMed ID: 15842331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological and clinical profile of superficial mycoses in the Monastir region (Tunisia). Retrospective study (1991-1994) of 3578 cases].
    Khorchani H; Haouet H; Amri M; Zanned I; Babba H; Azaiz R
    Arch Inst Pasteur Tunis; 1996; 73(3-4):179-84. PubMed ID: 9640498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and safety of stepwise exoderil therapy for otitis external mycotica].
    Kunel'skaia VIa; Shadrin GB
    Vestn Otorinolaringol; 2008; (5):59-62. PubMed ID: 19062415
    [No Abstract]   [Full Text] [Related]  

  • 16. [Emergent mycoses].
    Naito Y
    Nihon Jibiinkoka Gakkai Kaiho; 2004 Jul; 107(7):702-5. PubMed ID: 15386901
    [No Abstract]   [Full Text] [Related]  

  • 17. [State of the art diagnosis and treatment of ENT mycotic diseases].
    Kunel'skaia VIa
    Vestn Otorinolaringol; 2009; (4):75-8. PubMed ID: 19738598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycoses in otorhinolaryngology. Apropos of 167 cases].
    Ette A; Bamba M; Adjoua P; Boguifo J; Ette EE; Fakhry K; Therizol MF
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(2):173-7. PubMed ID: 2551027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traveller's molluscum.
    Collier D; Wiley E; Ward A; Hedley L
    Br J Hosp Med (Lond); 2014 Oct; 75(10):590-1. PubMed ID: 25291613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.